Portfolio

Our portfolio

Creating transformational companies at the forefront of life sciences, groundbreaking deep tech, and innovative climate tech.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Synchron is a clinical-stage neurotechnology company developing an endovascular brain-computer interface (BCI).

Cell Bauhaus is working to understand, predict, and alter cellular behaviour to harness the power of living organisms.

Porous Lane has developed highly permeable, environmentally friendly pathways that capture and reuse water.

Apromore has developed a collaborative process mining platform, allowing businesses to analyse their processes, and identify areas for optimisation.

Neurala Biosciences

Harnessing the power of botanically-inspired therapeutics

exteRNA is developing first-in-class inhibitors for the treatment of cancer.

Proxima Bio is developing degraders to target incurable diseases.

Gallant Bio is a pre-clinical stage company developing first-in-class treatments targeting a novel mechanism in obesity and type 2 diabetes.

No result found.